Hexagon Capital Partners LLC Merck & Co., Inc. Transaction History

Hexagon Capital Partners LLC

$508 Million
Q3 2024

A detailed history of Hexagon Capital Partners LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 5,343 shares of MRK stock, worth $544,344. This represents 0.12% of its overall portfolio holdings.

Number of Shares

5,343

Previous 5,513 3.08%

Holding current value

$544,344

Previous $682,000 11.14%

% of portfolio

0.12%

Previous 0.15%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$111.15 - $128.97 $18,895 - $21,924	-170 Reduced 3.08%	5,343 $606,000
Q2 2024 Jul 12, 2024	BUY	$123.8 - $132.96 $46,425 - $49,860	375 Added 7.3%	5,513 $682,000
Q1 2024 Apr 18, 2024	SELL	$113.24 - $131.95 $64,093 - $74,683	-566 Reduced 9.92%	5,138 $677,000
Q4 2023 Feb 05, 2024	BUY	$100.18 - $109.02 $211,179 - $229,814	2,108 Added 58.62%	5,704 $621,000
Q3 2023 Oct 23, 2023	SELL	$102.95 - $114.33 $41,797 - $46,417	-406 Reduced 10.14%	3,596 $370,000
Q2 2023 Jul 24, 2023	SELL	$108.61 - $118.38 $18,463 - $20,124	-170 Reduced 4.07%	4,002 $461,000
Q1 2023 Apr 24, 2023	SELL	$102.94 - $114.86 $100,057 - $111,643	-972 Reduced 18.9%	4,172 $443,000
Q4 2022 Jan 13, 2023	SELL	$87.44 - $112.11 $309,187 - $396,420	-3,536 Reduced 40.74%	5,144 $0
Q3 2022 Oct 17, 2022	BUY	$84.53 - $94.96 $219,186 - $246,231	2,593 Added 42.6%	8,680 $747,000
Q2 2022 Jul 21, 2022	BUY	$83.49 - $94.64 $81,987 - $92,936	982 Added 19.24%	6,087 $555,000
Q1 2022 Apr 13, 2022	BUY	$73.51 - $82.4 $19,186 - $21,506	261 Added 5.39%	5,105 $419,000
Q4 2021 Jan 27, 2022	BUY	$72.28 - $90.54 $24,213 - $30,330	335 Added 7.43%	4,844 $371,000
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $58,705 - $64,561	-819 Reduced 15.37%	4,509 $339,000
Q2 2021 Aug 11, 2021	BUY	$70.31 - $77.77 $95,340 - $105,456	1,356 Added 34.14%	5,328 $414,000
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $2,272 - $2,676	-33 Reduced 0.82%	3,972 $306,000
Q4 2020 Feb 05, 2021	BUY	$71.77 - $79.65 $1,004 - $1,115	14 Added 0.35%	4,005 $327,000
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $292,061 - $331,053	3,991 New	3,991 $306,000

Others Institutions Holding MRK

# of Institutions

3,808

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.

Account

Hexagon Capital Partners LLC Merck & Co., Inc. Transaction History